Changchun hi tech fell more than 8% in intraday diving

Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying

The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?

Cambridge Industries Group Plans Optical Module Capacity Expansion Across Four Countries

Cambridge Industries Group（剑桥科技）, or CIG, reaffirmed plans to add at least 10 million units of annual high-speed optical module capacity by the end of 2027. The expanded capacity will be allocated across production sites in China, Malaysia, Mexico and the United States.

Vital Optics Unit Signs InP Substrate Supply Letter of Intent with Coherent

Vital Optics（光智科技）said on November 6 that its controlling subsidiary Guangdong Xianrui Technology（广东先锐科技）had signed a long-term supply letter of intent with Coherent Corp.（高意）. The proposed supply of six-inch indium phosphide substrates from 2027 to 2029 has an estimated transaction value of no less than USD 601 million.

ByteDance Considers Second Phase of Brazil Data Centre Project

ByteDance（字节跳动）is seeking a developer for a potential second phase of its data centre project at the Port of Pecém in Brazil’s Ceará state, Bloomberg reported on November 6, citing people familiar with the plans. The proposed expansion remains under discussion.

Unpacking China | Key Chinese Firms to Watch This Week （1/11/2026-7/11/2026）

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.